![Hans Paul Walliser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Paul Walliser
Profile
Hans Paul Walliser worked as a Director of Biopharma Management Services at GE Healthcare Bio-Sciences, Technical Director at Vivendy Therapeutics Ltd., and Managing Director at Exyte Central Europe GmbH.
He also worked as a Principal at Novartis AG.
Walliser holds a doctorate degree from the University of Basel.
Former positions of Hans Paul Walliser
Companies | Position | End |
---|---|---|
Vivendy Therapeutics Ltd.
![]() Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Vivendy Therapeutics Ltd. develops enzyme replacement therapy and biological products. It has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity-enhancing the efficacy of the therapy in MPS IVA significantl. The company was founded in March 2006 and is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | 2014-03-09 |
GE Healthcare Bio-Sciences
![]() GE Healthcare Bio-Sciences Medical/Nursing ServicesHealth Services GE Healthcare Bio-sciences provides health care services. It makes purification systems that allow for the development of effective drugs through protein analysis, DNA sequencing and genetic variation. GE Healthcare Bio-sciences is headquartered in Little Chalfont, UK. | Corporate Officer/Principal | - |
Exyte Central Europe GmbH
![]() Exyte Central Europe GmbH Engineering & ConstructionIndustrial Services Exyte Central Europe GmbH engages in the planning and construction of processing plants and buildings. It also provides consulting, design, implementation, qualification and validation, as well as technical facility management services. The company was founded in 1995 and is headquartered in Stuttgart, Germany. | President | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Training of Hans Paul Walliser
University of Basel | Doctorate Degree |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
NOVARTIS AG | Health Technology |
Private companies | 3 |
---|---|
Vivendy Therapeutics Ltd.
![]() Vivendy Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Vivendy Therapeutics Ltd. develops enzyme replacement therapy and biological products. It has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity-enhancing the efficacy of the therapy in MPS IVA significantl. The company was founded in March 2006 and is headquartered in Basel, Switzerland. | Health Services |
Exyte Central Europe GmbH
![]() Exyte Central Europe GmbH Engineering & ConstructionIndustrial Services Exyte Central Europe GmbH engages in the planning and construction of processing plants and buildings. It also provides consulting, design, implementation, qualification and validation, as well as technical facility management services. The company was founded in 1995 and is headquartered in Stuttgart, Germany. | Industrial Services |
GE Healthcare Bio-Sciences
![]() GE Healthcare Bio-Sciences Medical/Nursing ServicesHealth Services GE Healthcare Bio-sciences provides health care services. It makes purification systems that allow for the development of effective drugs through protein analysis, DNA sequencing and genetic variation. GE Healthcare Bio-sciences is headquartered in Little Chalfont, UK. | Health Services |
- Stock Market
- Insiders
- Hans Paul Walliser